India
· Delayed Price · Currency is INR MedPlus Health Services Statistics
Total Valuation
NSE:MEDPLUS has a market cap or net worth of INR 98.22 billion. The enterprise value is 105.84 billion.
| Market Cap | 98.22B |
| Enterprise Value | 105.84B |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:MEDPLUS has 119.69 million shares outstanding. The number of shares has decreased by -7.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 119.69M |
| Shares Change (YoY) | -7.16% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 13.49% |
| Owned by Institutions (%) | 35.35% |
| Float | 69.12M |
Valuation Ratios
The trailing PE ratio is 74.43 and the forward PE ratio is 52.61. NSE:MEDPLUS's PEG ratio is 1.14.
| PE Ratio | 74.43 |
| Forward PE | 52.61 |
| PS Ratio | 1.61 |
| PB Ratio | 6.00 |
| P/TBV Ratio | 6.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.14 |
Enterprise Valuation
| EV / Earnings | 79.95 |
| EV / Sales | 1.73 |
| EV / EBITDA | 22.89 |
| EV / EBIT | 47.22 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 2.23 |
| Debt / FCF | n/a |
| Interest Coverage | 2.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.45% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 2.61M |
| Profits Per Employee | 56,538 |
| Employee Count | 23,415 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.23% in the last 52 weeks. The beta is 0.66, so NSE:MEDPLUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +19.23% |
| 50-Day Moving Average | 743.43 |
| 200-Day Moving Average | 726.20 |
| Relative Strength Index (RSI) | 67.28 |
| Average Volume (20 Days) | 154,043 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MEDPLUS had revenue of INR 61.17 billion and earned 1.32 billion in profits. Earnings per share was 11.03.
| Revenue | 61.17B |
| Gross Profit | 14.12B |
| Operating Income | 2.24B |
| Pretax Income | 1.54B |
| Net Income | 1.32B |
| EBITDA | 3.06B |
| EBIT | 2.24B |
| Earnings Per Share (EPS) | 11.03 |
Balance Sheet
The company has 2.68 billion in cash and 10.30 billion in debt, giving a net cash position of -7.62 billion or -63.67 per share.
| Cash & Cash Equivalents | 2.68B |
| Total Debt | 10.30B |
| Net Cash | -7.62B |
| Net Cash Per Share | -63.67 |
| Equity (Book Value) | 16.36B |
| Book Value Per Share | 136.87 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 23.09%, with operating and profit margins of 3.66% and 2.16%.
| Gross Margin | 23.09% |
| Operating Margin | 3.66% |
| Pretax Margin | 2.52% |
| Profit Margin | 2.16% |
| EBITDA Margin | 5.01% |
| EBIT Margin | 3.66% |
| FCF Margin | n/a |
Dividends & Yields
NSE:MEDPLUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.16% |
| Shareholder Yield | 7.16% |
| Earnings Yield | 1.35% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |